2003
DOI: 10.1016/s0264-410x(02)00703-x
|View full text |Cite
|
Sign up to set email alerts
|

Priming characteristics of peptide mimotopes of carbohydrate antigens

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
25
0

Year Published

2005
2005
2013
2013

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 40 publications
(26 citation statements)
references
References 31 publications
1
25
0
Order By: Relevance
“…Furthermore, the generated immune responses could be further manipulated with various delivery schedules, i.e. prime/boost strategies with peptides and carbohydrate, or a DNA vaccination approach (21,40). The presence of anti-GD2 ganglioside responses has already been investigated with application of mimicking peptides (29,41).…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, the generated immune responses could be further manipulated with various delivery schedules, i.e. prime/boost strategies with peptides and carbohydrate, or a DNA vaccination approach (21,40). The presence of anti-GD2 ganglioside responses has already been investigated with application of mimicking peptides (29,41).…”
Section: Discussionmentioning
confidence: 99%
“…Mimotopes function as xenoantigens and, consequently, can overcome tolerance to carbohydrate self-antigens. Unlike carbohydrate antigens and carbohydrate-conjugate vaccines, we have shown that mimotopes prime B-and T-cells for subsequent memory of carbohydrate antigens, facilitating long-term surveillance through recall of carbohydrate immune responses (23). This effect is a major advantage that would minimize the need for constant boosting.…”
Section: Introductionmentioning
confidence: 99%
“…Toward this end, we have shown that peptide mimotopes can induce humoral responses that mediate tumor-specific complement-dependent cytotoxicity (CDC) 3 (5,6) and tumorspecific cellular responses (7). We have also shown that priming with peptide mimotopes followed by boosting with carbohydrate Ag can prolong the IgM response in mice, a benefit that is perceived to be of value for cancer vaccines in humans (8). Because it is expected that complement inhibitors expressed on a tumor cell surface can impair CDC, we have turned our attention to a strategy of developing mimotopes that will induce Abs that trigger apoptotic mechanisms.…”
mentioning
confidence: 99%